160 related articles for article (PubMed ID: 36853404)
1. Microenvironmental elements singularity synergistically regulate the behavior and chemosensitivity of endometrioid carcinoma.
Morito S; Kawasaki M; Nishiyama M; Sakumoto T; Hashiguchi M; Narita T; Kawaguchi A; Toda S; Aoki S
Hum Cell; 2023 May; 36(3):1147-1159. PubMed ID: 36853404
[TBL] [Abstract][Full Text] [Related]
2. Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma.
Nagase K; Akutagawa T; Rikitake-Yamamoto M; Morito S; Futamata M; Tobu S; Noguchi M; Toda S; Aoki S
J Pathol; 2021 May; 254(1):46-56. PubMed ID: 33512712
[TBL] [Abstract][Full Text] [Related]
3. Oral-specific microenvironments regulate cell behavior and anticancer drug sensitivity of tongue squamous cell carcinoma.
Iwamoto S; Nishiyama M; Kawasaki M; Morito S; Sakumoto T; Toda S; Yamashita Y; Aoki S
Hum Cell; 2023 Mar; 36(2):643-656. PubMed ID: 36715868
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.
Zhang J; Jiang Y; Zhao Y; Wang W; Xie Y; Wang H; Yang Y
Tumour Biol; 2017 Jul; 39(7):1010428317712444. PubMed ID: 28718377
[TBL] [Abstract][Full Text] [Related]
5. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
[TBL] [Abstract][Full Text] [Related]
7. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
8. Cancer-adipose tissue interaction and fluid flow synergistically modulate cell kinetics, HER2 expression, and trastuzumab efficacy in gastric cancer.
Akutagawa T; Aoki S; Yamamoto-Rikitake M; Iwakiri R; Fujimoto K; Toda S
Gastric Cancer; 2018 Nov; 21(6):946-955. PubMed ID: 29696406
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo.
Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920
[TBL] [Abstract][Full Text] [Related]
10. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG.
Chen XP; Chen YG; Lan JY; Shen ZJ
Cancer Lett; 2014 Oct; 353(2):201-10. PubMed ID: 25063739
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin 3 Expression in Endometrioid Carcinoma of the Uterine Body Correlated With Early Stage and Lower Grade.
Watanabe T; Sato K; Kono T; Yamagishi Y; Kumazawa F; Miyamoto M; Takano M; Tsuda H
Pathol Oncol Res; 2020 Oct; 26(4):2247-2253. PubMed ID: 32382899
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies).
Ono R; Nakayama K; Nakamura K; Yamashita H; Ishibashi T; Ishikawa M; Minamoto T; Razia S; Ishikawa N; Otsuki Y; Nakayama S; Onuma H; Kurioka H; Kyo S
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370215
[TBL] [Abstract][Full Text] [Related]
14. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.
Marinelli O; Morelli MB; Annibali D; Aguzzi C; Zeppa L; Tuyaerts S; Amantini C; Amant F; Ferretti B; Maggi F; Santoni G; Nabissi M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751388
[TBL] [Abstract][Full Text] [Related]
16. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific Physical and Biological Microenvironments Modulate the Behavior of Cervical Squamous Cell Carcinoma.
Hanashima K; Akutagawa T; Yamamoto-Rikitake M; Sakumoto T; Futamata M; Nakao Y; Yokoyama M; Toda S; Aoki S
Acta Histochem Cytochem; 2021 Oct; 54(5):155-165. PubMed ID: 34764524
[TBL] [Abstract][Full Text] [Related]
18. SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION IN ENDOMETRIOID CARCINOMA OF DIFFERENT GRADE OF MALIGNANCY.
Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
Georgian Med News; 2018 Mar; (276):117-123. PubMed ID: 29697394
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
Byron SA; Loch DC; Pollock PM
Int J Gynecol Cancer; 2012 Nov; 22(9):1517-26. PubMed ID: 23060048
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines.
Attias-Geva Z; Bentov I; Fishman A; Werner H; Bruchim I
Gynecol Oncol; 2011 May; 121(2):383-9. PubMed ID: 21295335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]